Aquaculture Europe 2023

September 18 - 21, 2023

Vienna,Austria

Add To Calendar 21/09/2023 10:00:0021/09/2023 10:15:00Europe/ViennaAquaculture Europe 2023THE NUTRITIONAL COST OF MOUNTING THE IMMUNE RESPONSE IN A. SALMON Salmo salarStrauss 2The European Aquaculture Societywebmaster@aquaeas.orgfalseDD/MM/YYYYaaVZHLXMfzTRLzDrHmAi181982

THE NUTRITIONAL COST OF MOUNTING THE IMMUNE RESPONSE IN A. SALMON Salmo salar

C. Zarza, L. Jensen , P . Lisik and R. Fontanillas

 

 Skretting Aquaculture Innovation.

 Sjøhagen, 3. Stavanger 4016 , Norway.

 E-mail: ramon.fontanillas@skretting.com

 



Introduction

 Mounting the immune response and maintaining a competent immune system is thought to be a nutritionally demanding process.  In terrestrial animals, the influence of an immune challenge on animal growth is well established (Huntley et al., 2018). In fish, and particularly in A. salmon, it remains to be investigated.  An immune challenge and the associated lower feed intake can theoretically partition energy and nutrients away from productive processes such as muscle growth, and negatively impact efficiency.  In this work,  two experimental trials  were carried out  to  first  estimate the nutrient costs of immune stimulated A. salmon, and  second  to  design diets to support  the adequate immune response and performance during  an immune stimulation, using vaccination as challenge model.

Material and Methods

 To  validate vaccination as a  model to estimate nutrient utilisation during immune challenge a pilot trial (trial 1) was carried out in fresh water with A.salmon from 50 to 70g . Two groups of fish were vaccinated with either commercial vaccine 1 (V1) or commercial vaccine 2 (V2) ,  a  third group of fish was injected with a saline solution (S) and a fourth gr oup was used as a control (C). All fish were fed with the same commercial diet . At the beginning of the trial and a fter 24 days post vaccination fish were sampled for body composition  for nutrient balance estimation.  To  evaluate the dietary support to the immune response, a second trial (trial 2) was carried  out  with fish from 65 to 100g in fresh water. Three  groups of fish were immunized with  a  commercial vaccine after 17 days of feeding with one of the following diets: energy rich  (E), amino acid rich (A) and energy and amino acids ( EA).  A  fourth  group  consisted in non-injected fish (C)  fed a commercial diet served as control .  After 41 days post-immunisation, performance, n utrient retention,  immune response, and gene expression were the response parameters measured.

Results

In trial 1,  the  immune  stimulation response affected nutrient retention. Vaccinated fish (V1 and V2) showed  between 7 to 16% lower energy retention efficiency, between 15 to 20% lower fat retention and between 4 to 13% lower protein retention, in comparison with the non-vaccinated control group (C). Moreover, V2 fish showed lower amino acid retention efficiency for most of the amino acids in comparison with the rest of fish groups. In trial 2 , immunized fish ate  7% less compared to non-immunized.  Increasing dietary energy improved protein retention with  approximately 8%,  suggesting higher energy requirement  of immunized fish. Immune response was not different between dietary groups suggesting the  primary importance of immune function. There were differences in  gene expression regulation between dietary  treatments and immune stimulated fish.

Conclusion

 Overall, the results showed for the first time, the cost of mounting an immune response through vaccination in A. salmon . Nutrient retention and gene expression is modified under immune stimulation towards energy utilization , while the immune response was shown to be prioritized.  It is possible to design feeds to precisely support performance under  an  immune challenge.

References

 Huntley, N. F., Nyachoti, C. M., & Patience, J. F. (2018). Lipopolysaccharide immune stimulation but not β-mannanase supplementation affects maintenance energy requirements in young weaned pigs. Journal of Animal Science and Biotechnology, 9(1), 1–16. https://doi.org/10.1186/s40104-018-0264-y